The 2019 Penta guidelines for first and second line antiretroviral treatment are now available. The aim of these guidelines is to provide a concise reference document to guide antiretroviral choices for children and adolescents with perinatally acquired HIV in the European region. This document will be updated at regular intervals by the guidelines writing group or as significant new data or evidence becomes available.
A document summarising responses to the public consultation and writing group conflict of interest statements are available on request from email@example.com.
17th September, 2019